Srivastava S, Agarwal S, Gulati Y, Singh AK, Aggarwal P. Determining the role of SGLT2 inhibitors (dapagliflozin) on progression of proteinuria among non-diabetic adult patients with chronic kidney disease: a randomized controlled trial. Int J Adv Med [Internet]. 2025 Oct. 24 [cited 2025 Nov. 16];12(6):553-7. Available from: https://www.ijmedicine.com/index.php/ijam/article/view/4283